Globus Medical (GMED) Research & Development (2011 - 2026)

Globus Medical has reported Research & Development for 16 years, with the latest figure at $36.5 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 10.43% year-over-year to $36.5 million; the trailing twelve-month figure through Mar 2026 stood at $150.7 million (up 7.99% YoY), and the FY2025 full-year result was $147.2 million, down 10.08% from the prior year.
• Research & Development for Q1 2026 stood at $36.5 million, up from $36.2 million in the prior quarter.
• The five-year high for Research & Development was $52.3 million in Q4 2023, with the low at $12.6 million in Q1 2024.
• Historically, Research & Development has averaged $29.4 million across 5 years, with a median of $33.1 million in 2025.
• Annual changes were most pronounced in 2022 — Research & Development plunged 61.77% — and 2023, when it surged 167.86%.
• Globus Medical's Research & Development stood at $19.5 million in 2022, then surged by 167.86% to $52.3 million in 2023, then slumped by 36.06% to $33.4 million in 2024, then grew by 8.25% to $36.2 million in 2025, then climbed by 0.96% to $36.5 million in 2026.
• The last three Research & Development figures came in at $36.5 million (Q1 2026), $36.2 million (Q4 2025), and $38.1 million (Q3 2025), per Business Quant data.